Endo Health Solutions, Inc. (NASDAQ:ENDP)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

Recs

1
Player Avatar cajun1958 (27.12) Submitted: 3/20/2014 3:48:33 PM : Underperform Start Price: $72.98 ENDP Score: +10.12

Lack of anything new can be a problem in pharma when patents expire. ENDO is attempting to grow by acquisition but that rarely works especially when your competitors are after the same thing.

Featured Broker Partners


Advertisement